在ALS中微生物组和微量营养素:从新的机制到新的治疗方法
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA.
概括
肠道微生物组的变化和微量营养与肌缩性侧面硬化症 (ALS) 有关. 了解这些相互作用可能会揭示ALS患者的新诊断和治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种具有挑战性的神经退行性疾病.
- 最近的研究将肠道失生症,以微生物多样性和功能减少为特征,与ALS的肠道炎症和改变完整性联系起来.
- 肠道-微生物组-神经元轴因其在ALS病变发生中的作用而越来越受认可.
研究的目的:
- 审查最近在 ALS 研究中了解微生物组 (细菌,真菌,病毒) 的作用方面的进展.
- 讨论关于ALS中微生物代谢物的当前知识.
- 总结有关微量营养的文献及其与ALS的关系.
- 探索ALS进展和治疗中的微生物组和微量营养之间的相互作用.
主要方法:
- 对ALS微生物组研究的文献综述.
- 对微生物代谢物及其对ALS的影响的研究分析.
- 关于微量营养及其与ALS相关的研究结果的综合.
- 探索微生物组和微营养对ALS的联合影响.
主要成果:
- 包括改变微生物多样性和功能在内的肠道失调与ALS的肠道问题相关.
- 微生物代谢物和微量营养素是ALS病变发生的新兴因素.
- 肠道-微生物组-神经元轴在ALS进展中发挥着重要作用.
结论:
- 微生物组和微量营养是ALS研究的有希望的领域.
- 需要进一步的机制和翻译研究来弥合ALS的基础科学和临床应用.
- 研究肠道微生物和微营养之间的相互作用可能会导致ALS的新型诊断和治疗策略.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454


